Introduction
Thalassemia is a genetic disorder characterized by ineffective hematopoiesis, which iscaused by insufficient production of globin subunits and increased hemolysis. Patients with this disorder require frequent blood transfusions (1,2), which can cause iron accumulation in the heart that can lead to severe cardiac complications (3) .
Despite the improvements in chelation therapy, cardiac complications remain the main cause of mortality and morbidity in thalassemia major patients (4) . Several procedures have been used to detect the iron load in the heart. Echocardiography is a non-invasive, repeatable, and relatively inexpensive technique that is capable of the absolute diagnosis of heart diseases (5 (8) . T2* magnetic resonance allows for the preclinical detection of myocardial iron load, the prospective categorization of the cardiac risks, and the observation of the response to changes in chelation therapy (9) . However, its use in developing countries is limited because it is not cost-effective or easy to access.
In this study, we aimed to examine the efficiency of conventional echocardiography, tissue Doppler, and pulse-wave Doppler echocardiography, which are easy to access and economical compared to T2* magnetic resonance, for the detection of cardiac dysfunction at an early phase (i.e., before systolic dysfunction occurs) in beta thalassemia major patients. were not included in the study.
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Statistical Methods
Statistical evaluations were performed 
Results
The basic characteristic features of the beta thalassemia major patients and the healthy controls are summarized in Table 1 . Conventional echocardiographic data including left ventricle internal diameter at end-diastole, inter ventricular septal diastolic thickness, left ventricular diastolic mass, and left ventricular diastolic mass index were higher in the patient group than in the controls (p=0.009, p=0.009, p=0.026, p<0.001, respectively) ( Table 2 ). While diastolic dysfunction indicators 
Discussion
One of the main causes of mortality and morbidity in beta thalassemia major patients is iron accumulation due to blood transfusions (4).
Therefore, the ability to track cardiac dysfunction and cardiac iron load in these patients is vital. The 
